Back to Trades
ARCH Venture Partners XII, LLC
10% OwnerCIK 0001979548
Profile
- Filings
- 6
- Buy transactions
- 3
- Sell transactions
- 0
- Companies
- 5
- Active
- 2025–2026
Across 6 filings between 2025–2026, ARCH Venture Partners XII, LLC, 10% Owner, has disclosed $18.1M in transactions — spread across 5 companies. Their disclosed trades are heavily weighted toward buying — $18.1M in buys and $0 in sells. The largest single open-market purchase on record is $10.0M in Prime Medicine, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Oct 19 | CTY CITY THERAPEUTICS, INC. | ARCH Venture Partners XII, LLC | 10% Owner | Buy | $3.1M |
| Oct 15 | CTY CITY THERAPEUTICS, INC. | ARCH Venture Partners XII, LLC | 10% Owner | Other | $0 |
| Apr 30 | SPTX Seaport Therapeutics, Inc. | ARCH Venture Partners XII, LLC | Insider | Other | $0 |
| Nov 14 | MTSR Metsera, Inc. | ARCH Venture Partners XII, LLC | Director, 10% Owner | Disposed | $0 |
| Oct 29 | NMRA Neumora Therapeutics, Inc. | ARCH Venture Partners XII, LLC | 10% Owner | Buy | $5.0M |
| Aug 1 | PRME Prime Medicine, Inc. | ARCH Venture Partners XII, LLC | 10% Owner | Buy | $10.0M |
6 filings